SAREPTA THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 149787000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-09-30) |
| Status | current |
| Entity | SAREPTA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:35.123280+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ac023afc-8493-430b-a31c-5977e7ea67ce
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-21-002815Retrieved: 2026-08-19T08:39:35.123280+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000873303/accounts-receivable/2021-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ac023afc-8493-430b-a31c-5977e7ea67ce
History
- no predecessors — first report